The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DePaolo, R. W.
Right arrow Articles by Karpus, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DePaolo, R. W.
Right arrow Articles by Karpus, W. J.
The Journal of Immunology, 2003, 171: 3560-3567.
Copyright © 2003 by The American Association of Immunologists

CC Chemokine Ligand 2 and Its Receptor Regulate Mucosal Production of IL-12 and TGF-{beta} in High Dose Oral Tolerance 1

R. William DePaolo*, Barrett J. Rollins{dagger}, William Kuziel{ddagger} and William J. Karpus2,*

* Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611; {dagger} Dana Farber Cancer Institute, Harvard University School of Medicine, Boston, MA 02115; and {ddagger} Section of Molecular Genetics and Microbiology, and Institute for Cellular and Molecular Biology, University of Texas, Austin, TX 78712

Oral tolerance is the result of a complex immunoregulatory strategy used by the gut and its associated lymphoid tissues to render the peripheral immune system unresponsive to nonpathogenic proteins, such as food or commensal bacteria. The mechanism of oral tolerance induction and maintenance is not well understood. We have previously shown that the chemokine, CC chemokine ligand 2 (CCL2), is important for the induction and maintenance of oral tolerance. To address the role CCL2 plays in oral tolerance, we used both CCL2-/- and CCR2-/- mice. Cells from the spleen, mesenteric lymph nodes, and peripheral lymph nodes of CCL2-/- and CCR2-/- mice fed high doses of OVA showed robust proliferative responses compared with cells from Ag-fed wild-type mice. CCL2-/- and CCR2-/- mice also produced high amounts of Th1 cytokines such as IL-2 and IFN-{gamma} and very low amounts of IL-4 and IL-10. The ability of APCs from the gut of CCL2-/- and CCR2-/- OVA-fed mice to stimulate an indicator T cell line was evaluated. APCs from the Peyer’s patch of OVA-fed knockout animals could induce a T cell response measured by an increase in proliferation and generation of IL-12 and IFN-{gamma} with a concomitant reduction of TGF-{beta} compared with wild-type controls that did not induce a Th1 response. These data indicate that CCL2 and signaling through its receptor CCR2 is critical for the induction of oral tolerance by regulating Ag presentation leading to a disruption in the balance of inflammatory and regulatory cytokines.




This article has been cited by other articles:


Home page
BloodHome page
S. Rutella, G. Bonanno, A. Procoli, A. Mariotti, D. G. de Ritis, A. Curti, S. Danese, G. Pessina, S. Pandolfi, F. Natoni, et al.
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features
Blood, July 1, 2006; 108(1): 218 - 227.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. P. de Lema, H. Maier, T. J. Franz, M. Escribese, S. Chilla, S. Segerer, N. Camarasa, H. Schmid, B. Banas, S. Kalaydjiev, et al.
Chemokine Receptor Ccr2 Deficiency Reduces Renal Disease and Prolongs Survival in MRL/lpr Lupus-Prone Mice
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3592 - 3601.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. W. DePaolo, R. Lathan, B. J. Rollins, and W. J. Karpus
The Chemokine CCL2 Is Required for Control of Murine Gastric Salmonella enterica Infection
Infect. Immun., October 1, 2005; 73(10): 6514 - 6522.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. W. DePaolo, R. Lathan, and W. J. Karpus
CCR5 Regulates High Dose Oral Tolerance by Modulating CC Chemokine Ligand 2 Levels in the GALT
J. Immunol., July 1, 2004; 173(1): 314 - 320.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.